S
Description
The largest independent UK provider of small molecule API development and manufacturing services, with 50+ years of experience. Manages the most complex API and intermediate challenges from proof-of-concept to commercial manufacture, including ADC (Antibody Drug Conjugate) services. 1,350+ employees across six sites in UK (Cramlington, Newcastle, Deeside), US and Ireland. Self-defined as a PDMO® (Partnership DMO). MHRA, FDA and PMDA approved.